查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1550087

關節內粘稠補充療法市場:全球產業分析，規模，佔有率，成長，趨勢，2024-2033年預測

Viscosupplementation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發布了一份關於全球關節內替代治療市場的綜合報告。該報告對關鍵市場動態進行了詳細評估，包括市場推動因素、趨勢、機會和挑戰，並對市場結構提供了深入的見解。

主要的洞察

  • 關節內替代療法市場規模（2024 年）：59 億美元
  • 預計市值（2033 年）：136 億美元
  • 全球市場成長率（2024 年至 2033 年複合年增長率）：9.7%

關節內替代治療市場-報告範圍：

關節內替代療法，即在關節內注射玻尿酸或其他關節內替代療法，起到潤滑和緩解疼痛的作用，常用於治療骨關節炎。該市場包括多種產品類型，包括單次注射和多次注射的關節內替代治療，並供應給醫院、骨科診所和專科治療中心。骨關節炎盛行率的增加、老年人口的增加以及提高治療效果和患者預後的關節內替代治療技術的進步推動了市場成長。

市場推動因素：

全球關節內替代治療市場是由幾個關鍵因素推動的，例如骨關節炎盛行率的增加，這需要有效的管理解決方案。對非手術治療方案的認識不斷提高，以及容易患關節疾病的老年人口不斷增加，進一步推動了市場的成長。技術進步，例如改進的關節內替代治療配方和輸送系統的開發，提高了療效和患者舒適度。此外，關節內替代療法在其他關節疾病中的應用的擴大以及醫療保健投資的增加正在支持市場的擴張。

市場阻礙因素：

儘管成長潛力巨大，但關節內替代治療市場面臨著治療成本高且報銷範圍有限的挑戰。關節內替代療法注射的相關費用可能會成為獲得該療法的障礙，特別是在醫療保健預算有限的地區。此外，對關節內替代療法的長期安全性和有效性以及可能的副作用的擔憂可能會影響市場成長。解決這些問題需要努力提高成本效益並確保全面的安全評估。

市場機會：

由於技術進步、人口變化和不斷發展的醫療模式，關節內替代治療市場提供了巨大的商機。關節內替代治療產品的創新，例如改進的配方和緩釋系統，開闢了新的成長途徑。此外，微創手術的日益普及和再生醫學的進步為市場參與者提供了廣闊的前景。策略聯盟、研發投資以及實施具有成本效益的解決方案對於利用新機會和維持市場競爭力至關重要。

本報告涵蓋的主要問題

  • 推動全球關節內替代療法市場成長的關鍵因素是什麼？
  • 哪些類型的關節內替代治療產品正在各種醫療機構中獲得認可？
  • 技術進步如何影響關節內替代治療市場的競爭格局？
  • 誰是關節內替代治療市場的主要參與者？ 他們採取什麼策略來維持市場地位？
  • 全球關節內替代治療市場的新趨勢和未來前景如何？

目錄

第1章 摘要整理

第2章 市場概要

  • 市場範圍/分類
  • 市場定義/範圍/限制

第3章 市場風險與趨勢的評估

  • 風險評估
    • COVID-19危機和關節內粘稠補充療法的需求的影響
    • 過去的危機和比較了的COVID-19影響基準
    • 市場金額的影響(10億美元)
    • 主要國家的評估
    • 主要各市場區隔的評估
    • 與對供應商的行動點推薦事項
  • 影響市場的主要趨勢
  • 處方與產品開發趨勢

第4章 市場背景和基礎數據點

  • 全球關節內粘稠補充療法市場(10億美元)
  • 關節內粘稠補充療法市場機會評估(10億美元)
    • 整體市場規模
    • 服務可能的整體市場規模
    • 服務可能的可取得的市場
  • 市場情勢預測
    • 樂觀的情勢的需求
    • 預計的情勢的需求
    • 保守的情勢的需求
  • 投資可行性分析
    • 現有市場的投資
      • 短期性
      • 長期性
    • 新興市場的投資
      • 短期性
      • 長期性
  • 預測要素- 相關性及影響
    • 龍頭企業成長
    • 全球關節內粘稠補充療法市場成長
    • 地區冷氣引進率(各國)
  • 市場動態
    • 市場促進因素及影響評估
    • 主要的市場課題及影響評估
    • 關節內粘稠補充療法的市場機會
    • 全球市場的顯著的趨勢與其影響評估

第5章 重要成功要素

  • 廠商滲透率低高成長率市場著重
  • 市場區隔的高(貴)的增量機會賭
  • 同業基準

第6章 全球關節內粘稠補充療法市場需求分析

  • 過去的市場分析，2019-2023
  • 市場預測，2024～2033年
  • 與前一年同期比較成長趨勢分析

第7章 全球關節內粘稠補充療法市場金額分析

  • 市場金額(10億美元)分析，2019～2023年
  • 市場金額(10億美元)預測，2024～2033年
    • 與前一年同期比較成長趨勢分析
    • 絕對的商機

第8章 全球關節內粘稠補充療法市場分析:各產品類型

  • 簡介/主要調查結果
  • 市場規模(10億美元)分析，2019～2023年
  • 市場規模(10億美元)分析與預測，2024～2033年
    • 單回注射
    • 3次的注射
    • 5次的注射
  • 各產品類型的市場魅力分析

第9章 全球關節內粘稠補充療法市場分析:各終端用戶

  • 簡介/主要調查結果
  • 市場規模(10億美元)分析，2019～2023年
  • 市場規模(10億美元)分析與預測，2024～2033年
    • 醫院
    • 整形外科診所/門診病人手術中心(ASC)
  • 各終端用戶市場魅力分析

第10章 全球關節內粘稠補充療法市場分析:各地區

  • 簡介
  • 市場規模(10億美元)分析，2019～2023年
  • 市場規模(10億美元)分析與預測，2024～2033年
    • 北美
    • 南美
    • 歐洲
    • 亞太地區
    • 中東及非洲
  • 各地區市場的魅力分析

第11章 北美的關節內粘稠補充療法市場分析

第12章 南美的關節內粘稠補充療法市場分析

第13章 歐洲的關節內粘稠補充療法市場分析

第14章 亞太地區的關節內粘稠補充療法市場分析

第15章 中東及非洲的關節內粘稠補充療法市場分析

第16章 主要國家的關節內粘稠補充療法市場分析

  • 簡介
    • 各主要國家的市場金額比較起來分析
    • 與世界各國成長比較
  • 美國的關節內粘稠補充療法市場分析
    • 市場各分類價值比率分析
    • 市場各分類的價值與分析及預測，2019-2032年
      • 產品類型
      • 各終端用戶
  • 加拿大的關節內粘稠補充療法市場分析
    • 市場各分類價值比率分析
    • 市場各分類的價值與分析及預測，2019-2032年
      • 產品類型
      • 各終端用戶
  • 墨西哥的關節內粘稠補充療法市場分析
    • 市場各分類價值比率分析
    • 市場各分類的價值與分析及預測，2019-2032年
      • 產品類型
      • 各終端用戶
  • 巴西的關節內粘稠補充療法市場分析
    • 市場各分類價值比率分析
    • 市場各分類的價值與分析及預測，2019-2032年
      • 產品類型
      • 各終端用戶
  • 德國的關節內粘稠補充療法市場分析
    • 市場各分類價值比率分析
    • 市場各分類的價值與分析及預測，2019-2032年
      • 產品類型
      • 各終端用戶
  • 法國的關節內粘稠補充療法市場分析
    • 市場各分類價值比率分析
    • 市場各分類的價值與分析及預測，2019-2032年
      • 產品類型
      • 各終端用戶
  • 義大利的關節內粘稠補充療法市場分析
    • 市場各分類價值比率分析
    • 市場各分類的價值與分析及預測，2019-2032年
      • 產品類型
      • 各終端用戶
  • 荷比盧三國關節內粘稠補充療法市場分析
    • 市場各分類價值比率分析
    • 市場各分類的價值與分析及預測，2019-2032年
      • 產品類型
      • 各終端用戶
  • 英國關節內粘稠補充療法市場分析
    • 市場各分類價值比率分析
    • 市場各分類的價值與分析及預測，2019-2032年
      • 產品類型
      • 各終端用戶
  • 北歐各國的關節內粘稠補充療法市場分析
    • 市場各分類價值比率分析
    • 市場各分類的價值與分析及預測，2019-2032年
      • 產品類型
      • 各終端用戶
  • 中國關節內粘稠補充療法市場分析
    • 市場各分類價值比率分析
    • 市場各分類的價值與分析及預測，2019-2032年
      • 產品類型
      • 各終端用戶
  • 日本的關節內粘稠補充療法市場分析
    • 市場各分類價值比率分析
    • 市場各分類的價值與分析及預測，2019-2032年
      • 產品類型
      • 各終端用戶
  • 韓國的關節內粘稠補充療法市場分析
    • 市場各分類價值比率分析
    • 市場各分類的價值與分析及預測，2019-2032年
      • 產品類型
      • 各終端用戶
  • GCC各國的關節內粘稠補充療法市場分析
    • 市場各分類價值比率分析
    • 市場各分類的價值與分析及預測，2019-2032年
      • 產品類型
      • 各終端用戶
  • 南非的關節內粘稠補充療法市場分析
    • 市場各分類價值比率分析
    • 市場各分類的價值與分析及預測，2019-2032年
      • 產品類型
      • 各終端用戶
  • 土耳其的關節內粘稠補充療法市場分析
    • 市場各分類價值比率分析
    • 市場各分類的價值與分析及預測，2019-2032年
      • 產品類型
      • 各終端用戶
    • 國內的競爭情形和企業的集中度

第17章 市場結構分析

  • 各級企業市場分析
  • 市場集中
  • 主要企業的市場佔有率分析
  • 市場影響分析

第18章 競爭分析

  • 競爭儀表板
  • 競爭基準
  • 競爭詳細內容
    • Sanofi
    • Anika Therapeutics, Inc.
    • SEIKAGAKU CORPORATION
    • Zimmer Biomet
    • Smith &Nephew PLC
    • Ferring Pharmaceutical BV
    • Lifecore Biomedical, LLC(Landec)
    • LG Life Sciences Ltd.
    • Fidia Farmaceutici SpA
    • F.Hoffmann-La Roche Ltd.

第19章 所使用的前提條件與縮寫

第20章 調查手法

簡介目錄
Product Code: PMRREP33245

Persistence Market Research has recently released a comprehensive report on the global visco-supplementation market. This report provides an in-depth evaluation of key market dynamics, including drivers, trends, opportunities, and challenges, delivering detailed insights into the market structure.

Key Insights:

  • Visco-supplementation Market Size (2024E): USD 5.9 Billion
  • Projected Market Value (2033F): USD 13.6 Billion
  • Global Market Growth Rate (CAGR 2024 to 2033): 9.7%

Visco-supplementation Market - Report Scope:

Visco-supplementation involves the injection of hyaluronic acid or other viscosupplements into the joints to provide lubrication and relieve pain, commonly used in the treatment of osteoarthritis. The market includes various product types, such as single-injection and multi-injection viscosupplements, and caters to hospitals, orthopedic clinics, and specialized treatment centers. Market growth is driven by the increasing prevalence of osteoarthritis, rising geriatric population, and advancements in viscosupplement technology, enhancing treatment efficacy and patient outcomes.

Market Growth Drivers:

The global visco-supplementation market is driven by several key factors, including the growing incidence of osteoarthritis, which necessitates effective management solutions. The increasing awareness of non-surgical treatment options, coupled with the rising geriatric population prone to joint disorders, further propels market growth. Technological advancements, such as the development of improved viscosupplement formulations and delivery systems, offer enhanced efficacy and patient comfort. Additionally, the expanding application of viscosupplementation in other joint disorders and rising healthcare investments support market expansion.

Market Restraints:

Despite its promising growth potential, the visco-supplementation market faces challenges related to high treatment costs and limited reimbursement coverage. The expense associated with viscosupplement injections can be a barrier to access, particularly in regions with constrained healthcare budgets. Furthermore, concerns regarding the long-term safety and effectiveness of viscosupplementation treatments and the potential for adverse reactions may impact market growth. Addressing these issues requires efforts to improve cost-effectiveness and ensure comprehensive safety assessments.

Market Opportunities:

The visco-supplementation market presents significant opportunities driven by technological advancements, demographic shifts, and evolving healthcare models. Innovations in viscosupplement products, such as enhanced formulations and extended-release systems, create new growth avenues. Additionally, the increasing adoption of minimally invasive procedures and advancements in regenerative medicine offer promising prospects for market players. Strategic collaborations, investment in research and development, and the introduction of cost-effective solutions are crucial to capitalizing on emerging opportunities and maintaining market competitiveness.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the visco-supplementation market globally?
  • Which types of viscosupplement products are gaining traction across various healthcare settings?
  • How are technological advancements influencing the competitive landscape of the visco-supplementation market?
  • Who are the key players in the visco-supplementation market, and what strategies are they employing to sustain market relevance?
  • What are the emerging trends and future prospects in the global visco-supplementation market?

Competitive Intelligence and Business Strategy:

Leading players in the global visco-supplementation market, including Allergan, Anika Therapeutics, and Seikagaku Corporation, focus on innovation, product differentiation, and strategic partnerships to secure a competitive edge. These companies invest in R&D to develop advanced viscosupplement products, such as novel hyaluronic acid formulations and enhanced delivery systems. Collaborations with healthcare providers and distributors facilitate market access and promote technology adoption. Additionally, emphasis on clinical research, evidence-based practice, and patient education supports market growth and improves treatment outcomes in the evolving visco-supplementation landscape.

Key Companies Profiled:

  • Allergan
  • Anika Therapeutics
  • Seikagaku Corporation
  • Revive Therapeutics
  • Mylan N.V.
  • Ferring Pharmaceuticals
  • BioRestorative Therapies
  • OrthogenRx Inc.
  • Celgene Corporation
  • Merz Pharmaceuticals

Market Segments Covered in Viscosupplementation Market Industry Analysis

By Product Type

  • Single Injection
  • Three Injection
  • Five Injection

By End User

  • Hospitals
  • Orthopaedic Clinics/Ambulatory Surgical Centres (ASCs)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Summary of Statistics
  • 1.3. Key Market Characteristics & Attributes
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

  • 3.1. Risk Assessment
    • 3.1.1. COVID-19 Crisis and Impact on Viscosupplementation Demand
    • 3.1.2. COVID-19 Impact Benchmark with Previous Crisis
    • 3.1.3. Impact on Market Value (US$ Bn)
    • 3.1.4. Assessment by Key Countries
    • 3.1.5. Assessment by Key Market Segments
    • 3.1.6. Action Points and Recommendation for Suppliers
  • 3.2. Key Trends Impacting the Market
  • 3.3. Formulation and Product Development Trends

4. Market Background and Foundation Data Points

  • 4.1. Global Viscosupplementation Market (US$ Bn)
  • 4.2. Viscosupplementation Market Opportunity Assessment (US$ Bn)
    • 4.2.1. Total Available Market
    • 4.2.2. Serviceable Addressable Market
    • 4.2.3. Serviceable Obtainable Market
  • 4.3. Market Scenario Forecast
    • 4.3.1. Demand in optimistic Scenario
    • 4.3.2. Demand in Likely Scenario
    • 4.3.3. Demand in Conservative Scenario
  • 4.4. Investment Feasibility Analysis
    • 4.4.1. Investment in Established Markets
      • 4.4.1.1. In Short Term
      • 4.4.1.2. In Long Term
    • 4.4.2. Investment in Emerging Markets
      • 4.4.2.1. In Short Term
      • 4.4.2.2. In Long Term
  • 4.5. Forecast Factors - Relevance & Impact
    • 4.5.1. Top Companies Historical Growth
    • 4.5.2. Global Viscosupplementation Market Growth
    • 4.5.3. District Cooling Adoption Rate, By Country
  • 4.6. Market Dynamics
    • 4.6.1. Market Driving Factors and Impact Assessment
    • 4.6.2. Prominent Market Challenges and Impact Assessment
    • 4.6.3. Viscosupplementation Market Opportunities
    • 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

  • 5.1. Manufacturers' Focus on Low Penetration High Growth Markets
  • 5.2. Banking on with Segments High Incremental Opportunity
  • 5.3. Peer Benchmarking

6. Global Viscosupplementation Market Demand Analysis 2019-2023 and Forecast, 2024-2033

  • 6.1. Historical Market Analysis, 2019-2023
  • 6.2. Current and Future Market Projections, 2024-2033
  • 6.3. Y-o-Y Growth Trend Analysis

7. Global Viscosupplementation Market Value Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033, By Product Type

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
  • 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Product Type, 2024-2033
    • 8.3.1. Single Injection
    • 8.3.2. Three Injection
    • 8.3.3. Five Injection
  • 8.4. Market Attractiveness Analysis By Product Type

9. Global Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
    • 9.3.1. Hospitals
    • 9.3.2. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)
  • 9.4. Market Attractiveness Analysis By End User

10. Global Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
  • 10.3. Current Market Size (US$ Bn) & Analysis and Forecast By Region, 2024-2033
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. Asia Pacific
    • 10.3.5. Middle East and Africa (MEA)
  • 10.4. Market Attractiveness Analysis By Region

11. North America Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033

  • 11.1. Introduction
  • 11.2. Pricing Analysis
  • 11.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
    • 11.4.1. By Country
      • 11.4.1.1. U.S.
      • 11.4.1.2. Canada
      • 11.4.1.3. Rest of North America
    • 11.4.2. By Product Type
    • 11.4.3. By End User
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Country
    • 11.5.2. By Product Type
    • 11.5.3. By End User

12. Latin America Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Pricing Analysis
  • 12.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
    • 12.4.1. By Country
      • 12.4.1.1. Brazil
      • 12.4.1.2. Mexico
      • 12.4.1.3. Rest of Latin America
    • 12.4.2. By Product Type
    • 12.4.3. By End User
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Country
    • 12.5.2. By Product Type
    • 12.5.3. By End User

13. Europe Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Pricing Analysis
  • 13.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
    • 13.4.1. By Country
      • 13.4.1.1. Germany
      • 13.4.1.2. France
      • 13.4.1.3. U.K.
      • 13.4.1.4. Italy
      • 13.4.1.5. Benelux
      • 13.4.1.6. Nordic Countries
      • 13.4.1.7. Rest of Europe
    • 13.4.2. By Product Type
    • 13.4.3. By End User
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Country
    • 13.5.2. By Product Type
    • 13.5.3. By End User

14. Asia Pacific Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
    • 14.4.1. By Country
      • 14.4.1.1. China
      • 14.4.1.2. Japan
      • 14.4.1.3. South Korea
      • 14.4.1.4. Rest of Asia Pacific
    • 14.4.2. By Product Type
    • 14.4.3. By End User
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Product Type
    • 14.5.3. By End User

15. Middle East and Africa Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
    • 15.4.1. By Country
      • 15.4.1.1. GCC Countries
      • 15.4.1.2. South Africa
      • 15.4.1.3. Turkey
      • 15.4.1.4. Rest of Middle East and Africa
    • 15.4.2. By Product Type
    • 15.4.3. By End User
  • 15.5. Market Attractiveness Analysis
    • 15.5.1. By Country
    • 15.5.2. By Product Type
    • 15.5.3. By End User

16. Key Countries Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
    • 16.1.1. Market Value Proportion Analysis, By Key Countries
    • 16.1.2. Global Vs. Country Growth Comparison
  • 16.2. US Viscosupplementation Market Analysis
    • 16.2.1. Value Proportion Analysis by Market Taxonomy
    • 16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.2.2.1. By Product Type
      • 16.2.2.2. By End User
  • 16.3. Canada Viscosupplementation Market Analysis
    • 16.3.1. Value Proportion Analysis by Market Taxonomy
    • 16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.3.2.1. By Product Type
      • 16.3.2.2. By End User
  • 16.4. Mexico Viscosupplementation Market Analysis
    • 16.4.1. Value Proportion Analysis by Market Taxonomy
    • 16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.4.2.1. By Product Type
      • 16.4.2.2. By End User
  • 16.5. Brazil Viscosupplementation Market Analysis
    • 16.5.1. Value Proportion Analysis by Market Taxonomy
    • 16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.5.2.1. By Product Type
      • 16.5.2.2. By End User
  • 16.6. Germany Viscosupplementation Market Analysis
    • 16.6.1. Value Proportion Analysis by Market Taxonomy
    • 16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.6.2.1. By Product Type
      • 16.6.2.2. By End User
  • 16.7. France Viscosupplementation Market Analysis
    • 16.7.1. Value Proportion Analysis by Market Taxonomy
    • 16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.7.2.1. By Product Type
      • 16.7.2.2. By End User
  • 16.8. Italy Viscosupplementation Market Analysis
    • 16.8.1. Value Proportion Analysis by Market Taxonomy
    • 16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.8.2.1. By Product Type
      • 16.8.2.2. By End User
  • 16.9. BENELUX Viscosupplementation Market Analysis
    • 16.9.1. Value Proportion Analysis by Market Taxonomy
    • 16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.9.2.1. By Product Type
      • 16.9.2.2. By End User
  • 16.10. UK Viscosupplementation Market Analysis
    • 16.10.1. Value Proportion Analysis by Market Taxonomy
    • 16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.10.2.1. By Product Type
      • 16.10.2.2. By End User
  • 16.11. Nordic Countries Viscosupplementation Market Analysis
    • 16.11.1. Value Proportion Analysis by Market Taxonomy
    • 16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.11.2.1. By Product Type
      • 16.11.2.2. By End User
  • 16.12. China Viscosupplementation Market Analysis
    • 16.12.1. Value Proportion Analysis by Market Taxonomy
    • 16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.12.2.1. By Product Type
      • 16.12.2.2. By End User
  • 16.13. Japan Viscosupplementation Market Analysis
    • 16.13.1. Value Proportion Analysis by Market Taxonomy
    • 16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.13.2.1. By Product Type
      • 16.13.2.2. By End User
  • 16.14. South Korea Viscosupplementation Market Analysis
    • 16.14.1. Value Proportion Analysis by Market Taxonomy
    • 16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.14.2.1. By Product Type
      • 16.14.2.2. By End User
  • 16.15. GCC Countries Viscosupplementation Market Analysis
    • 16.15.1. Value Proportion Analysis by Market Taxonomy
    • 16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.15.2.1. By Product Type
      • 16.15.2.2. By End User
  • 16.16. South Africa Viscosupplementation Market Analysis
    • 16.16.1. Value Proportion Analysis by Market Taxonomy
    • 16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.16.2.1. By Product Type
      • 16.16.2.2. By End User
  • 16.17. Turkey Viscosupplementation Market Analysis
    • 16.17.1. Value Proportion Analysis by Market Taxonomy
    • 16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.17.2.1. By Product Type
      • 16.17.2.2. By End User
    • 16.17.3. Competition Landscape and Player Concentration in the Country

17. Market Structure Analysis

  • 17.1. Market Analysis by Tier of Companies
  • 17.2. Market Concentration
  • 17.3. Market Share Analysis of Top Players
  • 17.4. Market Presence Analysis
    • 17.4.1. By Regional footprint of Players
    • 17.4.2. Product footprint by Players

18. Competition Analysis

  • 18.1. Competition Dashboard
  • 18.2. Competition Benchmarking
  • 18.3. Competition Deep Dive
    • 18.3.1. Sanofi
      • 18.3.1.1. Overview
      • 18.3.1.2. Product Portfolio
      • 18.3.1.3. Sales Footprint
      • 18.3.1.4. Strategy Overview
    • 18.3.2. Anika Therapeutics, Inc.
      • 18.3.2.1. Overview
      • 18.3.2.2. Product Portfolio
      • 18.3.2.3. Sales Footprint
      • 18.3.2.4. Strategy Overview
    • 18.3.3. SEIKAGAKU CORPORATION
      • 18.3.3.1. Overview
      • 18.3.3.2. Product Portfolio
      • 18.3.3.3. Sales Footprint
      • 18.3.3.4. Strategy Overview
    • 18.3.4. Zimmer Biomet
      • 18.3.4.1. Overview
      • 18.3.4.2. Product Portfolio
      • 18.3.4.3. Sales Footprint
      • 18.3.4.4. Strategy Overview
    • 18.3.5. Smith & Nephew PLC
      • 18.3.5.1. Overview
      • 18.3.5.2. Product Portfolio
      • 18.3.5.3. Sales Footprint
      • 18.3.5.4. Strategy Overview
    • 18.3.6. Ferring Pharmaceutical B.V.
      • 18.3.6.1. Overview
      • 18.3.6.2. Product Portfolio
      • 18.3.6.3. Sales Footprint
      • 18.3.6.4. Strategy Overview
    • 18.3.7. Lifecore Biomedical, LLC (Landec)
      • 18.3.7.1. Overview
      • 18.3.7.2. Product Portfolio
      • 18.3.7.3. Sales Footprint
      • 18.3.7.4. Strategy Overview
    • 18.3.8. LG Life Sciences Ltd.
      • 18.3.8.1. Overview
      • 18.3.8.2. Product Portfolio
      • 18.3.8.3. Sales Footprint
      • 18.3.8.4. Strategy Overview
    • 18.3.9. Fidia Farmaceutici S.p.A
      • 18.3.9.1. Overview
      • 18.3.9.2. Product Portfolio
      • 18.3.9.3. Sales Footprint
      • 18.3.9.4. Strategy Overview
    • 18.3.10. F.Hoffmann-La Roche Ltd.
      • 18.3.10.1. Overview
      • 18.3.10.2. Product Portfolio
      • 18.3.10.3. Sales Footprint
      • 18.3.10.4. Strategy Overview

19. Assumptions and Acronyms Used

20. Research Methodology